The Risk for Developing Vision Threatening Diabetic Retinopathy is Influenced by Heredity to Diabetes

References

• Das T, Takkar B, Sivaprasad S, Thanksphon T, Taylor H, Wiedemann P, Nemeth J, Nayar PD, Rani PK, Khandekar R. Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities. Eye (Lond)). 2021;35(10):2685–2698. doi:10.1038/s41433-021-01572-4.
   PubMed Web of Science ®Google Scholar
• Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol. 2011;89(6):515–521. doi:10.1111/j.1755-3768.2009.01742.x.
   PubMed Web of Science ®Google Scholar
• Bek T. Systemic risk factors contribute differently to the development of proliferative diabetic retinopathy and clinically significant macular oedema. Diabetologia. 2020;63(11):2462–2470. doi:10.1007/s00125-020-05234-0.
   PubMed Web of Science ®Google Scholar
• Bauer W, Gyenesei A, Krętowski A. The multifactorial progression form the islet autoimmunity to type 1 diabetes in children. Int J Mol Sci. 2021;22(14):7493. doi:10.3390/ijms22147493.
   PubMed Web of Science ®Google Scholar
• Gurung RL, FitzGerald LM, McComish BJ, Verma N, Burdon KP. Identifying genetic risk factors for diabetic macular edema and the response to treatment. J Diabetes Res. 2020;2020:5016916. doi:10.1155/2020/5016916.
   PubMed Web of Science ®Google Scholar
• Sharma A, Valle ML, Beveridge C, Liu Y, Sharma S. Unraveling the role of genetics in the pathogenesis of diabetic retinopathy. Eye (Lond)). 2019;33(4):534–541. doi:10.1038/s41433-019-0337-y.
   PubMed Web of Science ®Google Scholar
• Padilla-Martínez F, Collin F, Kwasniewski M, Kretowski A. Systematic review of polygenic risk scores for type 1 and type 2 diabetes. Int J Mol Sci. 2020;21(5):1703. doi:10.3390/ijms21051703.
   PubMed Web of Science ®Google Scholar
• Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med. 2002;19(11):910–916. doi:10.1046/j.1464-5491.2002.00820.x.
   PubMed Web of Science ®Google Scholar
• Hallman DM, Huber JC, Gonzalez VH, Klein BEK, Klein R, Hanis CL. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005;28(5):1163–1168. doi:10.2337/diacare.28.5.1163.
   PubMed Web of Science ®Google Scholar
• Monti MC, Lonsdale JT, Montomoli C, Montross R, Schlag E, Greenberg DA. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab. 2007;92(12):4650–4655. doi:10.1210/jc.2007-1185.
   PubMed Web of Science ®Google Scholar
• Hietala K, Forsblom C, Summanen P, Groop P-H, on behalf of the FinnDiane Study Group Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57(8):2176–2180. doi:10.2337/db07-1495.
   PubMed Web of Science ®Google Scholar
• Bek T. Diabetic retinopathy: a review of the aarhus approach to studies on epidemiology, computerised grading, and the pathophysiology of the disease. Horm Metab Res. 2005;37 Suppl 1(Suppl 1):35–38. doi:10.1055/s-2005-861396.
   PubMed Web of Science ®Google Scholar
• Bek T, Tilma K, la Cour M. The risk for developing vision-threatening retinopathy after cataract surgery in diabetic patients depends on the postoperative follow-up time. Acta Ophthalmol. 2021;100(3):e719–e725. doi:10.1111/aos.14992.
   Web of Science ®Google Scholar
• Bek T. Incidence and risk for developing proliferative diabetic retinopathy after photocoagulation for diabetic maculopathy. Curr Eye Res. 2020;45(8):986–991. doi:10.1080/02713683.2020.1712729.
   PubMed Web of Science ®Google Scholar
• Bek T, Erlandsen M. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy. Acta Ophthalmol. 2005;84(1):16–20. doi:10.1111/j.1600-0420.2005.00574.x.
   Web of Science ®Google Scholar
• Bek T, Møller F, Klausen B. Short term visual prognosis after retinal laser photocoagulation for diabetic maculopathy. Acta Ophthalmol Scand. 2000;78(5):539–542. doi:10.1034/j.1600-0420.2000.078005539.x.
   PubMedGoogle Scholar
• Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med. 2007;26(24):4505–4519. doi:10.1002/sim.2864.
   PubMed Web of Science ®Google Scholar
• Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11(2):91–115. doi:10.1191/0962280202SM276ra.
   PubMed Web of Science ®Google Scholar
• Raftery AE. Bayesian model selection in social research. Soc Methodol. 1995;25:111–163. doi:10.2307/271063.
   Web of Science ®Google Scholar
• Bek T. Inner retinal ischaemia: current understanding and needs for further investigations. Acta Ophthalmol. 2009;87(4):362–367. doi:10.1111/j.1755-3768.2008.01429.x.
   PubMed Web of Science ®Google Scholar
• Bek T. Translational research in retinal vascular disease. An approach. Acta Ophthalmol. 2019;36(4):457–464.
   Google Scholar
• Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, Satko SG, Bowden DW, Duggirala R, Elston RC, et al. Heritability of the severity of diabetic retinopathy: The FIND-Eye study. Invest Ophthalmol Vis Sci. 2008;49(9):3839–3845. doi:10.1167/iovs.07-1633.
   PubMed Web of Science ®Google Scholar
• Li J, Dong Y, Wu T, Tong NJ. Differences between Western and Asian type 2 diabetes patients in the incidence of vascular complications and mortality: a systematic review of randomized controlled trials on lowering blood glucose. J Diabetes. 2016;8(6):824–833. doi:10.1111/1753-0407.12361.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research Group (DCCT). Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes. 1997;46(11):1829–1839.
   PubMed Web of Science ®Google Scholar
• Scanlon PH, Nevill CR, Stratton IM, Maruti SS, Massó-González EL, Sivaprasad S, Bailey C, Ehrlich M, Chong V. Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire. Acta Ophthalmol. 2022;100(2):e560–e570. doi:10.1111/aos.14927.
   PubMed Web of Science ®Google Scholar
• Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244–256. doi:10.1093/aje/kwp107.
   PubMed Web of Science ®Google Scholar
• Southern DA, Faris PD, Rollin Brant P, Galbraith PD, Norris CM, Knudtson ML, Ghali WA, APPROACH Investigators APPRIACH Investigators. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol. 2006;59(10):1110–1114. doi:10.1016/j.jclinepi.2006.07.002.
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes . Ophthalmology. 2008;115(11):1859–1868. doi:10.1016/j.ophtha.2008.08.023.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy XV. The long-term incidence of macular edema. Ophthalmology. 1995;102(1):7–16. doi:10.1016/s0161-6420(95)31052-4.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105(10):1801–1815. doi:10.1016/S0161-6420(98)91020-X.
   PubMed Web of Science ®Google Scholar
• Zureik A, Julla JB, Erginay A, Vidal-Trecan T, Juddoo V, Gautier JF, Massin P, Tadayoni R, Riveline P, Couturier A. Prevalence, severity stages, and risk factors of diabetic retinopathy in 1464 adult patients with type 1 diabetes. Graefes Arch Clin Exp Ophthalmol. 2021;259(12):3613–3623. doi:10.1007/s00417-021-05298-7.
   PubMed Web of Science ®Google Scholar
• Hove M, Kristensen JK, Lauritzen T, Bek T. The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand. 2006;84(5):619–623. doi:10.1111/j.1600-0420.2006.00710.x.
   PubMedGoogle Scholar
• Ometto G, Erlandsen M, Hunter A, Bek T. The role of retinopathy distribution and other lesion types for the definition of examination intervals during screening for diabetic retinopathy. Acta Ophthalmol. 2017;95(4):400–404. doi:10.1111/aos.13334.
   PubMed Web of Science ®Google Scholar
• Ometto G, Assheton P, Calivá F, Chudzik P, Al-Diri B, Hunter A, Bek T. Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy. Diabetologia. 2017;60(12):2361–2367. doi:10.1007/s00125-017-4424-y.
   PubMed Web of Science ®Google Scholar
• Sun JK, Aiello LP, Abràmoff MD, Antonetti DA, Dutta S, Pragnell M, Levine SR, Gardner TW. Updating the staging system for diabetic retinal disease. Ophthalmology. 2021;128(4):490–493. doi:10.1016/j.ophtha.2020.10.008.
   PubMed Web of Science ®Google Scholar